JP2020505352A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505352A5 JP2020505352A5 JP2019538525A JP2019538525A JP2020505352A5 JP 2020505352 A5 JP2020505352 A5 JP 2020505352A5 JP 2019538525 A JP2019538525 A JP 2019538525A JP 2019538525 A JP2019538525 A JP 2019538525A JP 2020505352 A5 JP2020505352 A5 JP 2020505352A5
- Authority
- JP
- Japan
- Prior art keywords
- alpha
- asn
- phe
- trp
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022193564A JP7819087B2 (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2025088409A JP2025162551A (ja) | 2017-01-18 | 2025-05-28 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762447778P | 2017-01-18 | 2017-01-18 | |
| US62/447,778 | 2017-01-18 | ||
| PCT/US2018/014257 WO2018136646A1 (en) | 2017-01-18 | 2018-01-18 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022193564A Division JP7819087B2 (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020505352A JP2020505352A (ja) | 2020-02-20 |
| JP2020505352A5 true JP2020505352A5 (enExample) | 2021-02-25 |
Family
ID=62908287
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019538525A Withdrawn JP2020505352A (ja) | 2017-01-18 | 2018-01-18 | インターロイキン−２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2022193564A Active JP7819087B2 (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2025088409A Pending JP2025162551A (ja) | 2017-01-18 | 2025-05-28 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022193564A Active JP7819087B2 (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2025088409A Pending JP2025162551A (ja) | 2017-01-18 | 2025-05-28 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20200207822A1 (enExample) |
| EP (1) | EP3570864B1 (enExample) |
| JP (3) | JP2020505352A (enExample) |
| AU (1) | AU2018210174B2 (enExample) |
| CA (1) | CA3049889A1 (enExample) |
| WO (1) | WO2018136646A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| HRP20211448T1 (hr) | 2014-05-16 | 2021-12-24 | Protagonist Therapeutics, Inc. | Alfa4beta7 integrin tioeter peptidni antagonisti |
| CN107206254B (zh) | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| WO2016054411A1 (en) | 2014-10-01 | 2016-04-07 | Protagonist Therapeutics, Inc. | NOVEL α4β7 PEPTIDE MONOMER AND DIMER ANTAGONISTS |
| US10301371B2 (en) | 2014-10-01 | 2019-05-28 | Protagonist Therapeutics, Inc. | Cyclic monomer and dimer peptides having integrin antagonist activity |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| US20190002503A1 (en) | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| US11021514B2 (en) | 2016-06-01 | 2021-06-01 | Athira Pharma, Inc. | Compounds |
| EP3681900A4 (en) | 2017-09-11 | 2021-09-08 | Protagonist Therapeutics, Inc. | OPIOID AGONIST PEPTIDES AND THEIR USES |
| CA3089868A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| WO2020014646A1 (en) | 2018-07-12 | 2020-01-16 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| JP7534382B2 (ja) * | 2019-07-10 | 2024-08-14 | プロタゴニスト セラピューティクス， インコーポレイテッド | インターロイキン－２３受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用 |
| WO2021007433A1 (en) * | 2019-07-10 | 2021-01-14 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| CA3167751A1 (en) | 2020-01-15 | 2021-07-22 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2021209086A1 (en) * | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| JP7397239B2 (ja) | 2020-11-20 | 2023-12-12 | ヤンセン ファーマシューティカ エヌ．ベー． | インターロイキン－２３受容体のペプチド阻害剤の組成物 |
| EP4370146A4 (en) | 2021-07-14 | 2025-05-21 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of the interleukin-23 receptor |
| TW202332683A (zh) * | 2021-07-14 | 2023-08-16 | 美商健生生物科技公司 | 介白素－２３受體之肽抑制劑 |
| AU2022402440A1 (en) | 2021-12-01 | 2024-05-30 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| CA3260606A1 (en) | 2022-06-30 | 2024-01-04 | Sanofi | NEW PEPTIDES FOR USE AS SELECTIVE IL-23 RECEPTOR ANTAGONISTS |
| CA3261954A1 (en) * | 2022-07-14 | 2024-01-18 | Janssen Pharmaceutica Nv | IL-23 CYCLIC PEPTIDE INHIBITORS |
| IL322125A (en) * | 2023-01-16 | 2025-09-01 | Janssen Pharmaceutica Nv | Formulations of interleukin-23 receptor peptide inhibitors linked to lipid residues |
| EP4471049A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| EP4471048A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| CN121909205A (zh) | 2023-09-08 | 2026-04-21 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| CN121794283A (zh) | 2023-09-08 | 2026-04-03 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| WO2025170982A2 (en) | 2024-02-06 | 2025-08-14 | Paragon Therapeutics, Inc. | Il-23 antibody compositions and methods of use |
| WO2026013260A1 (en) | 2024-07-12 | 2026-01-15 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| WO2026057052A1 (zh) * | 2024-09-14 | 2026-03-19 | 深圳信立泰药业股份有限公司 | 一种il-23受体抑制剂及其制备方法和用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030166138A1 (en) * | 2002-02-21 | 2003-09-04 | Todd Kinsella | Cyclic peptides and analogs useful to treat allergies |
| CA2677932A1 (en) | 2007-02-15 | 2008-08-21 | Indiana University Research And Technology Corporation | Glucagon/glp-1 receptor co-agonists |
| CA2707840A1 (en) | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Amino acid substituted molecules |
| US8946150B2 (en) | 2011-06-14 | 2015-02-03 | Medical Diagnostic Laboratories, LLC. | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| US9605027B2 (en) * | 2011-06-14 | 2017-03-28 | Medical Diagnostic Laboratories, Llc | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| CN107206254B (zh) | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| MX384213B (es) | 2015-07-15 | 2025-03-14 | Protagonist Therapeutics Inc | Inhibidores peptidicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias. |
| WO2018089693A2 (en) * | 2016-11-09 | 2018-05-17 | Protagonist Therapeutics, Inc. | Methods for determining and monitoring gastrointestinal inflammation |
-
2018
- 2018-01-18 WO PCT/US2018/014257 patent/WO2018136646A1/en not_active Ceased
- 2018-01-18 US US16/478,733 patent/US20200207822A1/en not_active Abandoned
- 2018-01-18 AU AU2018210174A patent/AU2018210174B2/en active Active
- 2018-01-18 CA CA3049889A patent/CA3049889A1/en active Pending
- 2018-01-18 JP JP2019538525A patent/JP2020505352A/ja not_active Withdrawn
- 2018-01-18 EP EP18741939.5A patent/EP3570864B1/en active Active
-
2022
- 2022-12-02 JP JP2022193564A patent/JP7819087B2/ja active Active
-
2023
- 2023-01-13 US US18/097,077 patent/US20240132558A1/en active Pending
-
2025
- 2025-05-28 JP JP2025088409A patent/JP2025162551A/ja active Pending